Beyond tissue.
Beyond mechanical.
Beyond long lasting.
BEYOND COMPARE.
TRIA™ heart valves are made with revolutionary new LifePolymer™ material and designed to last a lifetime. Our goal is to help millions of patients with aortic, mitral, and tricuspid valve disease receive cost-effective treatment in a single heart valve procedure.
Key advantages of TRIATM Heart valves
- Combines LifePolymer™—an advanced biopolymer—and a patented design to develop long-lasting heart valves without using animal tissue
- Developed to replace diseased heart valves via transcatheter or surgical delivery
- Designed to reduce or eliminate the need for a lifetime of anticoagulant drugs, including their risks and side effects
- Engineered to optimize hemodynamics and effective orifice areas
- Robotically manufactured for a high level of precision
LifePolymerTM –
A Material Difference
- Formulated for enhanced durability
- Thin leaflet material applicable to low TAVR profile
- Animal studies show no calcification or pannus formation
- No animal supply or potential BSE contamination issues1
- Robotic manufacturing for high volume/low overhead production
CHRONIC SHEEP STUDY
DESIGNED TO LAST A LIFETIME
- FEA designed – tailored to unique stresses of aortic and mitral positions
- TAVR valve designed to reduce profile without compromising durability
- Designed to optimize EOA and hemodynamics
- Engineered to resist leaflet damage propagation
AUTOMATED MANUFACTURING – A PARADIGM SHIFT
- Computer controlled, high volume manufacturing process increases output and decreases labor requirements
- Robotically assisted manufacturing process provides high quality precision
- High volume capacity and reduced labor needs result in lower per valve cost
LEARN HOW FOLDAX IS TRANSFORMING
HEART VALVE THERAPY
First Patients Outside of U.S. Treated with TRIA™ Polymer Surgical Mitral Heart Valve
Review Article: Polymer prosthetic heart valves: A review of current technologies and future directions
CRT23: TRIA TAVR Validation of Design in Chronic Ovine Model